Atlas Trials

Efficacy and Safety of Anti HCV Drugs in the Treatment of COVID-19

Clinical trial NCT04443725 · UNKNOWN

Trial details

NCT number
NCT04443725
Sponsor
Cairo University
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
COVID-19
Start date
2020-07-01
Primary completion
2020-10-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.